| Document |
Document Title |
|
WO/2007/039555A1 |
Oximether compounds of formula (I) wherein A is selected from A1 and A2; E is O or S(=O)r; r is 0, 1 or 2; X is C-Y or N; Y is halogen, CN, NO2, NH2, OH, SH, R1, OR1, SR1, S(=O)R1, S(=O)2R1, NHR1, NR1R2, C(=O)H, C(=O)R1, C(=O)OH, C(=O)OR...
|
|
WO/2007/036572A1 |
The invention relates to compounds of formula (I) which contain aldimine, and to the use thereof. Said compounds which contain aldimines are characterised in that they are odour-less and during hydrolysis the odour-free aldehydes are sep...
|
|
WO/2007/036571A1 |
The invention relates to aldimines of formula (I), the resulting products thereof, in addition to the uses thereof. The compounds containing aldimines and aldimines are characterised in that they are odour-free and during hydrolysis sepa...
|
|
WO/2007/025434A1 |
The present invention provides a new chloro-hypnone oxime derivative. The compound is prepared by the reaction of 1-(2,4-dichlorophenyl)-2-imidazol-1-yl-acetaldoxime, chloropropylene and the alkali in solvent. The compound can be used as...
|
|
WO/2007/023788A1 |
Disclosed is a benzonitrile derivative which is useful as a production intermediate for benzylamine derivative represented by the general formula (5) below and a secondary amine derivative represented by the general formula (9) below. Al...
|
|
WO/2007/020381A2 |
A process for the preparation of a compound of formula (I) wherein: R is an alkynyl group; R1 is alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkyl-alkyl, phenyl and phenylalkyl, it being possible in turn for all of the receding groups to c...
|
|
WO/2007/013697A1 |
Disclosed is a chiral phase-transfer catalyst having a simplified structure, which can be produced by reacting a 2,2'-dimethylenebromide-1,1'-binaphthyl derivative (which can be produced in relatively small numbers of steps) with a secon...
|
|
WO/2007/013698A1 |
Disclosed is a process for producing an asymmetric mono-substituted alkylated compound of an α-amino acid which is represented by a specific formula by using an aldimine-type Schiff base. In the process, the alkylation of an aldimine-ty...
|
|
WO/2007/009977A1 |
The present invention discloses active oligomerisation and polymerisation catalyst systems based on dioxime ligands.
|
|
WO/2007/007886A1 |
The problem of the present invention is to provide a useful compound as a glucokinase activating agent, which is the oxime derivative of the formula [I]: wherein Ring A is aryl or heteroaryl; Q is cycloalkyl, heterocycle, alkyl or alkeny...
|
|
WO/2007/008942A2 |
Hydrazide compounds with GPCR desensitization inhibitory activity are provided that may be used to influence, inhibit or reduce the action of a G-protein receptor kinase. Pharmaceutical compositions including therapeutically effective am...
|
|
WO/2007/002674A2 |
The present invention provides metal-containing compounds that include at least one β-diketiminate ligand, and methods of making and using the same. In some embodiments, the metal-containing compounds are homoleptic complexes that inclu...
|
|
WO/2007/000098A1 |
The invention, discloses substituted p-trifluoromethyl phenylethers of formula (I), the preparation and the use thereof, wherein each substituent is defined as in the description. The compounds of the invention have broad spectrum activi...
|
|
WO/2006/131482A1 |
Cinnamic and phenylpropiolic acid derivatives of Formula (I) having antitumour and chemosensitizing activity are described. Also described are pharmaceutical compositions containing the above-mentioned compounds, for the treatment of tum...
|
|
WO/2006/130405A2 |
Process for preparing mixtures comprising diphenylmethane diisocyantes and polyphenylpolymethylene polyisocyanates having a higher HunterLab color (L) number by staged reaction of the corresponding mixtures of diphenylmethanediamines and...
|
|
WO/2006/127205A2 |
The present invention relates to methods for preparing substituted 3-cyanoquinolines and intermediates obtained by the methods of the present invention. The methods of the invention comprise reacting an N-aryl-2-propanimide with phosphor...
|
|
WO/2006/127893A2 |
The present invention relates to processes for the production of 4-(biphenylyl)azetidin-2-one phosphonic acid derivatives of formula.
|
|
WO/2006/120888A1 |
[PROBLEMS] To provide near infrared ray absorbing compounds which are free from antimony and arsenic and which are excellent in stability, particularly in heat resistance, light fastness, and moist heat resistance; and infrared ray absor...
|
|
WO/2006/122020A2 |
The present invention relates to processes for the production of 4-biphenylylazetidin-2-one derivatives of formula (I).
|
|
WO/2006/119284A2 |
Disclosed herein are compounds, compositions and methods for using such compounds and compositions in the treatment of hyperproliferative conditions, including precancerous and cancerous conditions. In one embodiment, the compounds inclu...
|
|
WO/2006/109442A1 |
A process by which not only aromatic aldehydes but also aliphatic aldehydes can be converted into optically active &agr -hydroxyphosphonic acids or derivatives thereof with sufficiently high enantioselectivity, more specifically, a proce...
|
|
WO/2006/108864A2 |
This invention is related to new nitrogenated trans-stilbene analog compounds, more specifically, imine, pyrrol and Índole derivatives, with procedures for the preparation and use thereof as pharmaceutical compositions for the treatment...
|
|
WO/2006/104226A1 |
A chiral phase-transfer catalyst represented by the following formula (I). (I) The compound (I) can be produced by reacting 1,1'-biphenyl 2,2'-dimethylenebromide derivative which can be produced through a relatively small number of steps...
|
|
WO/2006/104528A1 |
This invention provides aromatic diimines where the diimines have imino groups with at least two carbon atoms, and either are in the form of one benzene ring having two imino groups on the ring, which imino groups are meta or para relati...
|
|
WO/2006/089954A2 |
The invention relates to novel compounds with formula (I) and their use in stabilization of Factor VIIa or other Factor VII polypeptides, particularly in aqueous liquid compositions thereof.
|
|
WO/2006/087874A1 |
A process for producing an optically active epoxy compound on an industrial scale, comprising carrying out asymmetric epoxidation of a prochiral unsaturated compound with an oxidizer in the presence of, as a catalyst, a monomer represent...
|
|
WO/2006/086517A2 |
Bisaryloxime ethers and bisarylhydroazones are shown to be effective for inhibiting formation of amyloid fibrils of transthyretin.
|
|
WO/2006/085048A2 |
A pro-odorant or pro-flavorant that is liquid at room temperature and has a relatively low viscosity and has the formula (I): wherein R1 is H, an aliphatic group or an aromatic group, R2 is an aliphatic group or an aromatic group, provid...
|
|
WO/2006/084031A1 |
The present invention provides a class of chemical compounds useful in the treatment of sickle cell disease, diseases characterized by unwanted or abnormal cell proliferation and for the treatment of ocular disorders such as glaucoma. Th...
|
|
WO/2006/081807A2 |
The invention relates to a novel method for the production of losartan, an imidazol derivative with the chemical name 2-n-butyl-4-chloro-5-hydroxymethyl-1-{[2'-(1H-tetrazol-5-yl)
biphenyl-4-]methyl}imidazol and the pharmacologically acti...
|
|
WO/2006/069685A1 |
The invention relates to compounds of formula (I), where A1, A2, R1, R2, R3, R4, R5 and Y have the meanings given in the description, methods and intermediates for production thereof and use thereof for the prevention of pests.
|
|
WO/2006/067416A1 |
The present invention provides a process for the formation of an enamide (III) wherein each R is independently selected from (1-6C)alkyl, benzyl and C(O)(1-6C)alkyl, or two RO groups together form a (1-4C)alkylenedioxy group, comprising ...
|
|
WO/2006/059867A1 |
2-cyclopenten-1-one oxime derivatives represented by Formula (I), or pharmaceutically acceptable salts thereof inhibit the production of TNF-&agr or PDE4, and therefore show therapeutic effect in inflammatory or immunological disorders m...
|
|
WO/2006/057505A1 |
The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPAR&gammad ) and alpha (PPAR&agr ), processes of preparing the same, and pharmaceutical compositions contain...
|
|
WO/2006/057503A1 |
The present invention relates to novel compounds accelerating the activity of Peroxisome proliferator-activated receptor gamma (PPAR&gammad ) and alpha (PPAR&agr ), processes of preparing the same, and pharmaceutical compositions contain...
|
|
WO/2006/054366A1 |
A method of synthesizing an optically active amino acid and a derivative thereof in a two-phase system consisting of a water-immiscible medium and an alkaline aqueous solution using as a phase-transfer catalyst an optically active quater...
|
|
WO/2006/050402A1 |
The present invention relates to gibbane derivatives of formula (I), their synthesis, and their use as estrogen receptor modulators. The compounds of the instant invention are ligands for estrogen receptors and as such may be useful for ...
|
|
WO/2006/048547A1 |
The invention relates to synthesis organic chemistry, in particular to a novel method for synthesising zwitterionic benzoquinonemonoimine derivatives, to certain novel obtained derivatives, the use thereof in the form of colorants or dye...
|
|
WO/2006/041000A1 |
Disclosed is a titanium compound prepared from an optically active ligand represented by the following general formula (1) (wherein R2, R3 and R4 independently represent a hydrogen atom, an alkyl group or the like, and A* represents a hy...
|
|
WO/2006/040462A1 |
The invention relates to ester compounds of 2-hydroxy-4-[2-hydroxyimino-2-(5,5,8,8-tetramethyl-5,6,7,8-t
etrahydro-naphthalene-2-yl)-ethoxy]-benzoic acid, to the synthesis method thereof and to the uses of same in the medical and cosmeti...
|
|
WO/2006/037496A1 |
Novel dihalogenopropene derivatives of the formula (I) and of the formula (Ia), wherein A, A1, A2, G, Q, R1, R2, R3, R4, and X have the meaning provided in the description, Methods and intermediates for their production as well as their ...
|
|
WO/2006/029436A1 |
The invention relates to the compounds of the general formula (I), wherein X = -CH- or -N=, n = 0 or 1, R1 = -H, -F, -OCH3 or -COOCH3, R2 = -H or -F, R3 = -H, or R2 and R3 together represent -CH2-CH2-, R4 = -H or -OCH3, R5 = -H, -OCH3 or...
|
|
WO/2006/027454A1 |
The invention relates to compounds of formula (I): where X + Y = keto, or X = OH and Y =H, or X + Y = oxime or methyloxime, B = OH and C + D =H, or C + D = C1-C4 linear or branched alkyl, or C = H and D = C1-C4 linear or branched alkyl, ...
|
|
WO/2006/029135A1 |
A process for preparing indanylamine and aminotetralin derivatives from indanone or tetralone oximes by acylating the oximes with an organic anhydride, followed by catalytic hydrogenation in the presence of an organic anhydride with subs...
|
|
WO/2006/028006A1 |
Disclosed is a near infrared absorbing compound which does not contain antimony or arsenic and has excellent stability, especially excellent heat resistance, light resistance and wet heat resistance. Also disclosed are a near-infrared ab...
|
|
WO/2006/026251A1 |
The subject invention provides compounds which are easily metabolized by the metabolic drug detoxification systems. Particularly, fluvoxamine analogs which have been designed to include esters within the structure of the compounds are ta...
|
|
WO/2006/016248A1 |
The present invention relates to a delivery system in the form of a dynamic mixture obtained by reacting together, in the presence of water, at least one hydrazine derivative with at least one perfuming, flavoring, insect repellent or at...
|
|
WO/2006/015200A1 |
The present invention relates to novel 1,3-diimines and 1,3-diimine copper complexes and the use of 1,3-diimine copper complexes for the deposition of copper on substrates or in or on porous solids in an atomic layer deposition process.
|
|
WO/2006/011669A1 |
Novel cinnamic acid-related compounds and salts thereof which are useful as drugs, specifically, compounds represented by the general formula [1] and salts thereof: [1] wherein A is a six-membered hydrocarbon ring or a six-membered heter...
|
|
WO/2006/010598A1 |
The invention relates to a category of non-glycosidic and non-peptidic select inhibitors of general formula (1), with a low molecular weight, and to a method for the production thereof. Said category is a category of non-toxic select inh...
|
